Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Muscle-invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05123625
What this trial is testing

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 200
Large-scale testing (Phase 3)Study completedNCT00006124
What this trial is testing

Celecoxib in Treating Patients With Bladder Cancer

Who this might be right for
Recurrent Bladder Cancer
National Cancer Institute (NCI) 152
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Testing effectiveness (Phase 2)Study completedNCT02844816
What this trial is testing

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT03081858
What this trial is testing

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder Cancer+7 more
Lipac Oncology LLC 15
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Not applicableLooking for participantsNCT04564781
What this trial is testing

Predicting BCG Response

Who this might be right for
Bladder Cancer
Cedars-Sinai Medical Center 400
Not applicableLooking for participantsNCT07187635
What this trial is testing

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital 196
Large-scale testing (Phase 3)UnknownNCT04736394
What this trial is testing

Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Testing effectiveness (Phase 2)Study completedNCT00595088
What this trial is testing

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Anchiano Therapeutics Israel Ltd. 47
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Not applicableLooking for participantsNCT05464576
What this trial is testing

Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis

Who this might be right for
Urinary Bladder TumourMRIInvasion+1 more
University Hospital, Clermont-Ferrand 150
Large-scale testing (Phase 3)Study completedNCT00445601
What this trial is testing

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 406
Early research (Phase 1)Study completedNCT03258593
What this trial is testing

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Who this might be right for
Urinary Bladder Neoplasms
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00238420
What this trial is testing

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 70
Not applicableLooking for participantsNCT07225127
What this trial is testing

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Who this might be right for
Bladder CancerRecurrent Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC)
University of Washington 408
Large-scale testing (Phase 3)UnknownNCT00816075
What this trial is testing

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Who this might be right for
Recurrent Superficial Bladder CancerDistilled Water
Bozyaka Training and Research Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03520491
What this trial is testing

Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 52
Not applicableLooking for participantsNCT05672615
What this trial is testing

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Johns Hopkins University 42
Early research (Phase 1)Study completedNCT02311101
What this trial is testing

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasm
The University of Texas Health Science Center at San Antonio 18
Next Page